These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Thymogen in the complex treatment of inflammatory diseases of the female genital system].
    Author: Tsvelev IuV, Khavinson VKh, Diachuk AV, Gur'ev AV, Seryĭ SV.
    Journal: Akush Ginekol (Mosk); 1992 Feb; (2):54-7. PubMed ID: 1476231.
    Abstract:
    Thymogen, a new immunomodulating drug made in this country, was used in combined therapy of 46 patients with acute endomyometritis, exacerbations of chronic salpingo-oophoritis, purulent tubo-ovarian formations. Thymogen therapy was conducive to normalization of lymphocyte counts, absolute counts of T and B lymphocytes, increase of T lymphocyte functional activity. The drug is characterized by a desensitizing effect and induces no complications. Marked clinical effect recommends the immunomodulator thymogen for combined therapy of patients with inflammatory diseases of the uterus and its appendages.
    [Abstract] [Full Text] [Related] [New Search]